NCT00797082

Brief Summary

The aim of the study is to assess the efficacy of cardiac MRI to detect coronary disease in diabetic patients. Cardiac MRI will be compared to myocardial scintigraphy with is the method being used in current practice. The investigators believe that cardiac MRI will be as efficient if not better that myocardial scintigraphy to detect tight coronary artery stenosis with the advantage of providing no radiation to the patient. Moreover, the investigators believe that cardiac MR will add additional information regarding possible undetected myocardial infarction.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Nov 2008

Longer than P75 for phase_4

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 27, 2008

Completed
5 days until next milestone

Study Start

First participant enrolled

November 1, 2008

Completed
24 days until next milestone

First Posted

Study publicly available on registry

November 25, 2008

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2011

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2012

Completed
Last Updated

July 31, 2012

Status Verified

July 1, 2012

Enrollment Period

2.3 years

First QC Date

October 27, 2008

Last Update Submit

July 29, 2012

Conditions

Keywords

DiabeticCoronary diseaseAtherosclerosisMagnetic resonance imagingMyocardial Perfusion ScintigraphyCoronary angiography

Outcome Measures

Primary Outcomes (1)

  • positive diagnosis of coronary artery disease.

    2 days

Secondary Outcomes (1)

  • cost efficacy analysis for the diagnosis of coronary insufficiency in diabetic patients free of known coronary disease

    26 months

Study Arms (1)

1

EXPERIMENTAL

MRI = Myocardial Perfusion Stress and MPS = Myocardial Perfusion Scintigraphy * Diabetic patients * Coronary insufficiency

Device: MRIDevice: MPS

Interventions

MRIDEVICE

MRI = Myocardial Perfusion Stress

1
MPSDEVICE

MPS = Myocardial Perfusion Scintigraphy

1

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient older than 18 years old
  • Patient with health care coverage ( social security or universal health coverage - CMU)
  • Patient who had a prior medical examination
  • Diabetic patient (type 1 or type 2) with no known coronary artery disease, addressed for myocardial scintigraphy
  • Patient who was informed of objectives and constraints of the study and having given his consent in writing

You may not qualify if:

  • Pregnant and lactating women
  • Patients with known coronary disease (myocardial infarction, unstable angina, history of coronary artery disease)
  • Patient with contra-indication for MRI claustrophobia, metallic foreign body in the eye, pacemakers, mechanical heart valve laid before 1985 Patient with specific contra-indication to vasodilators
  • Severe hypotension \< 90 mmHg
  • Hypersensitivity to adenosine or dipyridamole
  • Bronchial asthma, chronic obstructive pulmonary disease with obvious bronchospasm. Severe and known pulmonary artery hypertension
  • Atrioventricular 2nd or 3rd degree blocks, long QT syndrome
  • Tight known carotid artery stenosis (70% NASCET criterion), with no possible vascular substitution
  • Patient with contra-indication to cardiac stimulation
  • Unstable hemodynamic state and / or unstable angina not stabilized by drug treatment and/or decompensated or severe heart failure
  • Known comorbidities : pregnancy and lactation, tight aortic valve or mitral valve stenosis, severe left-right shunt, severe pericarditis or abundant pericardial effusion
  • Contra-indication to coronary angiography
  • Renal failure with creatinine clearance \< 30 ml / min
  • Hypersensitivity to contrast agents that resulted in a serious complication

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hopital Bichat

Paris, 75018, France

Location

MeSH Terms

Conditions

Coronary DiseaseAtherosclerosis

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesArteriosclerosisArterial Occlusive Diseases

Study Officials

  • Jean Michel SERFATY, PHU

    ASSISTANCE PUBLIQUE

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
NA
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 27, 2008

First Posted

November 25, 2008

Study Start

November 1, 2008

Primary Completion

March 1, 2011

Study Completion

July 1, 2012

Last Updated

July 31, 2012

Record last verified: 2012-07

Locations